Opportunity Information: Apply for RFA AG 20 006
The Interpersonal Processes in Alzheimer's Disease and Related Dementias: Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional) funding opportunity (RFA-AG-20-006) is a National Institutes of Health research grant designed to push forward what is known about communication and relationship dynamics in the context of Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The central idea is that day-to-day interactions among people living with dementia, their family or other caregivers, and health care practitioners strongly shape care quality, treatment adherence, stress levels, safety, and overall well-being. This initiative supports research intended to generate practical, evidence-based strategies and interventions that improve communication and help sustain supportive caregiving relationships as the disease progresses across settings and stages of care.
A major emphasis of the announcement is intervention-relevant science, meaning the research should be positioned to inform or directly build approaches that can be used in real clinical and caregiving environments. The opportunity invites both basic research (to better understand mechanisms and interpersonal processes) and translational research (to convert those insights into tools, programs, or practices). While clinical trials are optional under this R01, applicants can propose studies that range from foundational observational or mechanistic work to pilot testing, refinement, and evaluation of intervention components, depending on what best fits the project aims and readiness of the science.
The solicitation highlights two high-priority research areas. The first is effective communication and relationship functioning among patients, health care practitioners, and caregivers. Projects in this area could focus on how communication can be improved during clinical encounters, care planning conversations, delivery of diagnoses and prognoses, medication management discussions, behavioral symptom management, transitions between care settings, and shared decision-making as cognitive abilities change. The underlying goal is to reduce misunderstandings, improve alignment on care goals, and support dignity and person-centered care, while also ensuring caregivers are effectively integrated into clinical processes when appropriate.
The second priority area is the link between close relationship processes and health outcomes within caregiving relationships. This includes studying how relationship qualities and interpersonal dynamics such as support, conflict, empathy, reciprocity, emotional contagion, burden sharing, trust, and coping patterns relate to mental and physical health for both the person with dementia and the caregiver. It also points toward identifying protective factors that help sustain caregiver resilience and patient well-being, as well as risk factors that can lead to caregiver burnout, depression, poor health behaviors, or breakdowns in care. Research responsive to this area typically aims to clarify what relationship mechanisms matter most and how they might be strengthened through targeted supports.
In practical terms, this R01 is aimed at improving the human side of dementia care: how people talk to each other, how they coordinate care, and how they maintain workable, supportive partnerships under high stress and changing abilities. The expectation is that funded work will advance knowledge that can be translated into better training for clinicians, better support structures for caregivers, improved communication tools or protocols, and interventions that preserve relationship quality and functioning across the dementia care continuum.
Eligibility for the opportunity is broad, spanning many types of applicants. Eligible entities include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly notes additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This wide eligibility is consistent with an emphasis on diverse research settings, community engagement, and culturally informed approaches to caregiving and clinical communication.
Administratively, this is a discretionary NIH grant in the health area (CFDA 93.866). The original closing date listed is 2019-10-23, and an award ceiling of $500,000 is noted in the source information. Overall, the opportunity is targeted at strengthening the evidence base for how interpersonal and relational factors can be leveraged to improve outcomes in AD/ADRD, with a clear focus on producing knowledge that can realistically be turned into interventions and better care practices.Apply for RFA AG 20 006
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-06-05.
- Applicants must submit their applications by 2019-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Integrated Research, Education, and Extension Competitive Grants Program – Organic Transitions
Previous opportunity: Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 006
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed) Apply for RFA HL 20 017 Funding Number: RFA HL 20 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 036 Funding Number: RFA AG 20 036 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed) Apply for RFA HL 20 015 Funding Number: RFA HL 20 015 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Diversity Program Consortium Dissemination and Translation Awards (U01 - Clinical Trial Not Allowed) Apply for RFA RM 19 003 Funding Number: RFA RM 19 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) Apply for PAR 19 296 Funding Number: PAR 19 296 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences (R01 - Clinical Trial Not Allowed) Apply for PAR 19 295 Funding Number: PAR 19 295 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) Apply for PAR 19 297 Funding Number: PAR 19 297 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional) Apply for RFA AG 20 022 Funding Number: RFA AG 20 022 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U24 Clinical Trial Not Allowed) Apply for RFA MH 20 215 Funding Number: RFA MH 20 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 Clinical Trial Not Allowed) Apply for RFA NS 19 039 Funding Number: RFA NS 19 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed) Apply for RFA AG 20 007 Funding Number: RFA AG 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) Apply for PAR 19 298 Funding Number: PAR 19 298 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) Apply for PAR 19 299 Funding Number: PAR 19 299 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Country Health Information Systems and Data Use (CHISU) Apply for 7200AA19R00065 Funding Number: 7200AA19R00065 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) Apply for PAR 19 300 Funding Number: PAR 19 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 009 Funding Number: RFA RM 19 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 010 Funding Number: RFA RM 19 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 039 Funding Number: RFA AG 20 039 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 19 302 Funding Number: PAR 19 302 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301 Funding Number: PAR 19 301 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
